Multi-platform analysis of Telomerase Reverse Transcriptase (TERT) gene alterations in Hepatocellular Carcinoma (HCC)
Dhanasekaran, R., Covington, K., Watt, J., Cherniack, A. D., O'Brien, D. R., Lee, J.-S., … Wheeler, D. A. (2015). Multi-platform analysis of Telomerase Reverse Transcriptase (TERT) gene alterations in Hepatocellular Carcinoma (HCC). Presented at the 66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), SAN FRANCISCO,CA,CA: WILEY-BLACKWELL.

Quality of Cancer Care in Patients with Cirrhosis and Hepatocellular Carcinoma.
Dhanasekaran, R., & Talwalkar, J. A. (2015). Quality of Cancer Care in Patients with Cirrhosis and Hepatocellular Carcinoma. Current Gastroenterology Reports, 17(9), 34-?

Activation of the Transforming Growth Factor-beta/SMAD Transcriptional Pathway Underlies a Novel Tumor-Promoting Role of Sulfatase 1 in Hepatocellular Carcinoma
Dhanasekaran, R., Nakamura, I., Hu, C., Chen, G., Oseini, A. M., Seven, E. S., … Roberts, L. R. (2015). Activation of the Transforming Growth Factor-beta/SMAD Transcriptional Pathway Underlies a Novel Tumor-Promoting Role of Sulfatase 1 in Hepatocellular Carcinoma. HEPATOLOGY, 61(4), 1269–83.

Vasodilator-Stimulated Phosphoprotein Promotes Activation of Hepatic Stellate Cells by Regulating Rab11-Dependent Plasma Membrane Targeting of Transforming Growth Factor Beta Receptors
Tu, K., Li, J., Verma, V. K., Liu, C., Billadeau, D. D., Lamprecht, G., … Kang, N. (2015). Vasodilator-Stimulated Phosphoprotein Promotes Activation of Hepatic Stellate Cells by Regulating Rab11-Dependent Plasma Membrane Targeting of Transforming Growth Factor Beta Receptors. HEPATOLOGY, 61(1), 361–374.

Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study.
Xing, M., Prajapati, H. J., Dhanasekaran, R., Lawson, D. H., Kokabi, N., Eaton, B. R., & Kim, H. S. (2017). Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study. American Journal of Clinical Oncology, 40(1), 27–34.

Challenges of recurrent hepatitis C in the liver transplant patient
Dhanasekaran, R., & Firpi, R. J. (2014). Challenges of recurrent hepatitis C in the liver transplant patient. WORLD JOURNAL OF GASTROENTEROLOGY, 20(13), 3391–3400.

A potential role for type XVIII collagen as a suppressor of hepatocellular carcinoma
Duncan, M., Dhanasekaran, R., Thakur, P., & Roberts, L. R. (2014). A potential role for type XVIII collagen as a suppressor of hepatocellular carcinoma. Presented at the 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, BOSTON,MA: WILEY-BLACKWELL.

Hepatic Preservation Injury: Severity of Hepatitis C Recurrence and Survival After Liver Transplantation
Michaels, A. J., Dhanasekaran, R., Foley, D. P., Alkhasawneh, A., Dixon, L., Soldevila-Pico, C., … Firpi, R. J. (2013). Hepatic Preservation Injury: Severity of Hepatitis C Recurrence and Survival After Liver Transplantation. DIGESTIVE DISEASES AND SCIENCES, 58(5), 1403–1409.

Chinese skullcap in move free arthritis supplement causes drug induced liver injury and pulmonary infiltrates.
Dhanasekaran, R., Owens, V., & Sanchez, W. (2013). Chinese skullcap in move free arthritis supplement causes drug induced liver injury and pulmonary infiltrates. Case Reports in Hepatology, 2013, 965092-?

Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma
Dhanasekaran, R., Hemming, A. W., Zendejas, I., George, T., Nelson, D. R., Soldevila-Pico, C., … Cabrera, R. (2013). Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma. ONCOLOGY REPORTS, 29(4), 1259–67.

Analysis of Paired Biopsies to Assess Progression of Fibrosis in Patients Treated for Post-Transplant Hepatitis C Recurrence
Dhanasekaran, R., Charlton, M. R., & Sanchez, W. (2013). Analysis of Paired Biopsies to Assess Progression of Fibrosis in Patients Treated for Post-Transplant Hepatitis C Recurrence. GASTROENTEROLOGY, 144(5), S1028–S1028.

Safety and Efficacy of Doxorubicin Drug-eluting Bead Transarterial Chemoembolization in Patients with Advanced Hepatocellular Carcinoma
Prajapati, H. J., Dhanasekaran, R., El-Rayes, B. F., Kauh, J. S., Maithel, S. K., Chen, Z., & Kim, H. S. (2013). Safety and Efficacy of Doxorubicin Drug-eluting Bead Transarterial Chemoembolization in Patients with Advanced Hepatocellular Carcinoma. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 24(3), 307–315.

Liver Test Results Do Not Identify Liver Disease in Adults With alpha(1)-Antitrypsin Deficiency
Clark, V. C., Dhanasekaran, R., Brantly, M., Rouhani, F., Schreck, P., & Nelson, D. R. (2012). Liver Test Results Do Not Identify Liver Disease in Adults With alpha(1)-Antitrypsin Deficiency. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 10(11), 1278–1283.

The Impact of Pre transplant Transarterial Therapy in Hepatocellular Carcinoma
Pannu, D. S., Dhanasekaran, R., Bahaaeldeen, I., Zendejas, I., Firpi, R. J., Soldevila-Pico, C., … Cabrera, R. (2012). The Impact of Pre transplant Transarterial Therapy in Hepatocellular Carcinoma. Presented at the 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease (AASLD), BOSTON,MA: WILEY-BLACKWELL.

Incidentally discovered HCC (iHCC) in explant liver- Clinical and histopathologic features and outcome
Dhanasekaran, R., Pannu, D. S., Ismail, B., Zendejas, I., Firpi, R. L., Soldevila-Pico, C., … Cabrera, R. (2012). Incidentally discovered HCC (iHCC) in explant liver- Clinical and histopathologic features and outcome. Presented at the 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease (AASLD), BOSTON,MA: WILEY-BLACKWELL.

Rare case of adult undifferentiated (embryonal) sarcoma of the liver treated with liver transplantation: excellent long-term survival.
Dhanasekaran, R., Hemming, A., Salazar, E., & Cabrera, R. (2012). Rare case of adult undifferentiated (embryonal) sarcoma of the liver treated with liver transplantation: excellent long-term survival. Case Reports in Hepatology, 2012, 519741-?

Impact of Transarterial Therapy in Hepatitis C-Related Hepatocellular Carcinoma on Long-term Outcomes After Liver Transplantation
Cabrera, R., Dhanasekaran, R., Caridi, J., Clark, V., Morelli, G., Soldevila-Pico, C., … Firpi, R. J. (2012). Impact of Transarterial Therapy in Hepatitis C-Related Hepatocellular Carcinoma on Long-term Outcomes After Liver Transplantation. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 35(4), 345–350.

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics.
Dhanasekaran, R., Limaye, A., & Cabrera, R. (2012). Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepatic Medicine : Evidence and Research, 4, 19–37.

Tumoral and angiogenesis factors in hepatocellular carcinoma after locoregional therapy
Farris, A. B., Dursun, N., Dhanasekaran, R., Coban, I., McIntosh, E. B., Adsay, N. V., & Kim, H. S. (2012). Tumoral and angiogenesis factors in hepatocellular carcinoma after locoregional therapy. PATHOLOGY RESEARCH AND PRACTICE, 208(1), 15–21.

THE IMPACT OF PRESERVATION INJURY ON ACCELERATED HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION
Michaels, A., Dhanasekaran, R., Alkhasawneh, A., Dixon, L., Soldevila-Pico, C., Morelli, G. (J., … Firpi, R. J. (2010). THE IMPACT OF PRESERVATION INJURY ON ACCELERATED HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION. HEPATOLOGY, 52(4), 320A–320A.

MULTIVARIATE SURVIVAL ANALYSIS OF PREDICTIVE FACTORS OF HEPATOCELLULAR CARCINOMA TREATED WITH DOXORUBICIN DRUG ELUTING BEADS TRANSCATHETER CHEMOEMBOLIZATION
Dhanasekaran, R., Rafi, S., El-Rayes, B. F., Kauh, J. S., Kooby, D. A., & Kim, H. S. (2010). MULTIVARIATE SURVIVAL ANALYSIS OF PREDICTIVE FACTORS OF HEPATOCELLULAR CARCINOMA TREATED WITH DOXORUBICIN DRUG ELUTING BEADS TRANSCATHETER CHEMOEMBOLIZATION. HEPATOLOGY, 52(4), 1165A–1166A.

The Effectiveness of Locoregional Therapies versus Supportive Care in Maintaining Survival within the Milan Criteria in Patients with Hepatocellular Carcinoma
Dhanasekaran, R., Khanna, V., Kooby, D. A., Spivey, J. R., Parekh, S., Knechtle, S. J., … Kim, H. S. (2010). The Effectiveness of Locoregional Therapies versus Supportive Care in Maintaining Survival within the Milan Criteria in Patients with Hepatocellular Carcinoma. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 21(8), 1197–1204.

Long-term survival after locoregional therapy in patients with unresectable hepatocellular carcinoma: Improvements over two decades.
Dhanasekaran, R., McIntosh, E. B., Kauh, J. S., Kooby, D. A., El-rayes, B. F., & Kim, H. S. (2010). Long-term survival after locoregional therapy in patients with unresectable hepatocellular carcinoma: Improvements over two decades. JOURNAL OF CLINICAL ONCOLOGY, 28(15).

Chemoembolization with doxorubicin drug-eluting beads for unresectable hepatocelluar carcinoma with portal vein thrombosis
McIntosh, E. B., Dhanasekaran, R., Kauh, J. S., El-rayes, B. F., Kooby, D. A., Williams, R. S., & Kim, H. S. (2010). Chemoembolization with doxorubicin drug-eluting beads for unresectable hepatocelluar carcinoma with portal vein thrombosis. JOURNAL OF CLINICAL ONCOLOGY, 28(15).

Tumoral and angiogenesis factors in hepatocellular carcinoma (HCC) after drug eluting bead (DEB) transarterial chemoembolization (TACE) with doxorubicin
Farris, A. B., Dhanasekaran, R., Dursun, N., Coban, I., McIntosh, E. B., Adsay, V., & Kim, H. S. (2010). Tumoral and angiogenesis factors in hepatocellular carcinoma (HCC) after drug eluting bead (DEB) transarterial chemoembolization (TACE) with doxorubicin. JOURNAL OF CLINICAL ONCOLOGY, 28(15).

Comparison of Conventional Transarterial Chemoembolization (TACE) and Chemoembolization With Doxorubicin Drug Eluting Beads (DEB) for Unresectable Hepatocelluar Carcinoma (HCC)
Dhanasekaran, R., Kooby, D. A., Staley, C. A., Kauh, J. S., Khanna, V., & Kim, H. S. (2010). Comparison of Conventional Transarterial Chemoembolization (TACE) and Chemoembolization With Doxorubicin Drug Eluting Beads (DEB) for Unresectable Hepatocelluar Carcinoma (HCC). JOURNAL OF SURGICAL ONCOLOGY, 101(6), 476–480.

Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study
Dhanasekaran, R., Kooby, D. A., Staley, C. A., Kauh, J. S., Khanna, V., & Kim, H. S. (2010). Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study. HPB, 12(3), 174–180.

Transjugular Intrahepatic Portosystemic Shunt for Symptomatic Refractory Hepatic Hydrothorax in Patients With Cirrhosis
Dhanasekaran, R., West, J. K., Gonzales, P. C., Subramanian, R., Parekh, S., Spivey, J. R., … Kim, H. S. (2010). Transjugular Intrahepatic Portosystemic Shunt for Symptomatic Refractory Hepatic Hydrothorax in Patients With Cirrhosis. AMERICAN JOURNAL OF GASTROENTEROLOGY, 105(3), 635–641.

PREDICTORS OF EARLY MORTALITY AFTER TRAN-SJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTS (TIPS)
Dhanasekaran, R., Gonzales, P. C., West, J., Subramanian, R., Parekh, S., Spivey, J. R., … Kim, H. S. (2009). PREDICTORS OF EARLY MORTALITY AFTER TRAN-SJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTS (TIPS). HEPATOLOGY, 50(4), 436A–437A.

High-risk factors affecting survival after transcatheter therapy with doxorubicin-eluting beads for unresectable hepatocellular carcinoma
West, J. K., Dhanasekaran, R., Kooby, D. A., Staley, C. A., Kauh, J., & Kim, H. S. (2009). High-risk factors affecting survival after transcatheter therapy with doxorubicin-eluting beads for unresectable hepatocellular carcinoma. JOURNAL OF CLINICAL ONCOLOGY, 27(15).

Locoregional therapies as a bridge to transplant in patients with hepatocellular carcinoma
Sakaria, S. S., Dhanasekaran, R., Pankonin, M., Parekh, S., Kauh, J. S., & Kim, H. S. (2009). Locoregional therapies as a bridge to transplant in patients with hepatocellular carcinoma. JOURNAL OF CLINICAL ONCOLOGY, 27(15).

Drug eluting beads versus conventional TACE for unresectable hepatocellular carcinoma: Survival benefits and safety
Dhanasekaran, R., Kooby, D. A., Staley, C. A., Kauh, J. S., & Kim, H. S. (2009). Drug eluting beads versus conventional TACE for unresectable hepatocellular carcinoma: Survival benefits and safety. JOURNAL OF CLINICAL ONCOLOGY, 27(15).

Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances.
Dhanasekaran, R., Bandoh, S., & Roberts, L. R. (2016). Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances. F1000Research, 5.

Management of Immunosuppression in Liver Transplantation
Dhanasekaran, R. (2017). Management of Immunosuppression in Liver Transplantation. CLINICS IN LIVER DISEASE, 21(2), 337-?

Transcriptional Induction of Periostin by a Sulfatase 2-TGF beta 1-SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular Carcinoma
Chen, G., Nakamura, I., Dhanasekaran, R., Iguchi, E., Tolosa, E. J., Romecin, P. A., … Roberts, L. R. (2017). Transcriptional Induction of Periostin by a Sulfatase 2-TGF beta 1-SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular Carcinoma. CANCER RESEARCH, 77(3), 632–45.

Selective Internal Yttrium-90 Radioembolization Therapy (Y-90-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy Safety and Efficacy Cohort Study
Xing, M., Prajapat, H. J., Dhanasekaran, R., Lawson, D. H., Kokabi, N., Eaton, B. R., & Kim, H. S. (2017). Selective Internal Yttrium-90 Radioembolization Therapy (Y-90-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy Safety and Efficacy Cohort Study. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 40(1), 27–34.

Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.
Xing, M., Sakaria, S., Dhanasekaran, R., Parekh, S., Spivey, J., Knechtle, S. J., … Kim, H. S. (2017). Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma. Cardiovascular and Interventional Radiology, 40(3), 410–20.

Prognostic Value of F-18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Predicting Survival in Patients with Unresectable Metastatic Melanoma to the Liver Undergoing Yttrium-90 Radioembolization
Piduru, S. M., Schuster, D. M., Barron, B. J., Dhanasekaran, R., Lawson, D. H., & Kim, H. S. (2012). Prognostic Value of F-18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Predicting Survival in Patients with Unresectable Metastatic Melanoma to the Liver Undergoing Yttrium-90 Radioembolization. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 23(7), 943–948.

ALT ABNORMALITIES IN ADULTS WITH ALPHA-1 ANTITRYPSIN DEFICIENCY
Clark, V., Brantly, M., Dhanasekaran, R., Schreck, P., Rouhani, F., & Nelson, D. (2011). ALT ABNORMALITIES IN ADULTS WITH ALPHA-1 ANTITRYPSIN DEFICIENCY. Presented at the 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), BERLIN,GERMANY,GERMANY: ELSEVIER SCIENCE BV.

Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/ß-catenin-induced FGF18 expression in hepatocellular carcinoma.
Guo, P., Wang, Y., Dai, C., Tao, C., Wu, F., Xie, X., … Chen, G. (2018). Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/ß-catenin-induced FGF18 expression in hepatocellular carcinoma. Oncogene, 37(9), 1220–36.

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. (2017). Cell, 169(7), 1327–1341.e23.

YAP-associated chromosomal instability and cholangiocarcinoma in mice.
Rizvi, S., Fischbach, S. R., Bronk, S. F., Hirsova, P., Krishnan, A., Dhanasekaran, R., … Gores, G. J. (2018). YAP-associated chromosomal instability and cholangiocarcinoma in mice. Oncotarget, 9(5), 5892–5905.

Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC).
Dhanasekaran, R., Gabay-Ryan, M., Baylot, V., Lai, I., Mosley, A., Huang, X., … Felsher, D. W. (2018). Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC). Oncotarget, 9(5), 5517–28.

The Liver in Oncology.
Dhanasekaran, R., & Kwo, P. Y. (2017). The Liver in Oncology. Clinics in Liver Disease, 21(4), 697–707.

Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas
Campbell, J. D., Yau, C., Bowlby, R., Liu, Y., Brennan, K., Fan, H., … Van Waes, C. (2018). Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas. CELL REPORTS, 23(1), 194-+.

The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Yang, T.-H. O., … Shmulevich, L. (2018). The Immune Landscape of Cancer. IMMUNITY, 48(4), 812-+.

Rising Inpatient Healthcare Resource Utilization in Baby Boomers with Hepatocellular Carcinoma
Cholankeril, G., Al Juboori, A., Perumpail, R. B., Yoo, E. R., Hu, M., Dhanasekaran, R., … Ahmed, A. (2016). Rising Inpatient Healthcare Resource Utilization in Baby Boomers with Hepatocellular Carcinoma. HEPATOLOGY, 64, 679A.

Differences in Hepatocellular Carcinoma Incidence and Survival Rates among Asian Mono-Ethnicities
Cholankeril, G., Perumpail, R. B., Hu, M., Pham, E. A., Kumari, R., Gish, R., … Ahmed, A. (2016). Differences in Hepatocellular Carcinoma Incidence and Survival Rates among Asian Mono-Ethnicities. HEPATOLOGY. WILEY.

Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
Liu, Y., Sethi, N. S., Hinoue, T., Schneider, B. G., Cherniack, A. D., Sanchez-Vega, F., … Laird, P. W. (2018). Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. CANCER CELL, 33(4), 721-+.

Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Malta, T. M., Sokolov, A., Gentles, A. J., Burzykowski, T., Poisson, L., Weinstein, J. N., … Wiznerowicz, M. (2018). Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. CELL, 173(2), 338-+.

Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers.
Peng, X., Chen, Z., Farshidfar, F., Xu, X., Lorenzi, P. L., Wang, Y., … Liang, H. (2018). Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers. Cell Reports, 23(1), 255–69.e4.

Direct-Acting Antiviral Therapy Significantly Reduces Early HCC Recurrence: A Multicenter US Cohort Study
Singal, A. G., Mehta, N., Rich, N. E., Murphy, C., Branch, A. D., Pillai, A. A., … Parikh, N. D. (2018). Direct-Acting Antiviral Therapy Significantly Reduces Early HCC Recurrence: A Multicenter US Cohort Study. HEPATOLOGY, 68, 58A–59A.

Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.
Dhanasekaran, R., Nault, J.-C., Roberts, L. R., & Zucman-Rossi, J. (2018). Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy. Gastroenterology.

Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma.
Lai, I., Swaminathan, S., Baylot, V., Mosley, A., Dhanasekaran, R., Gabay, M., & Felsher, D. W. (2018). Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma. Journal for Immunotherapy of Cancer, 6(1), 125.

MYC Functions As a Master Switch for Natural Killer Cell-Mediated Immune Surveillance of Lymphoid Malignancies
Swaminathan, S., Heftdal, L. D., Liefwalker, D. F., Dhanasekaran, R., Deutzmann, A., Horton, C., … Felsher, D. (2018). MYC Functions As a Master Switch for Natural Killer Cell-Mediated Immune Surveillance of Lymphoid Malignancies. BLOOD, 132.

A Tale of Two Complications of Obesity: Nonalcoholic steatohepatitis (NASH) and Hepatocellular carcinoma (HCC).
Dhanasekaran, R., & Felsher, D. W. (2019). A Tale of Two Complications of Obesity: Nonalcoholic steatohepatitis (NASH) and Hepatocellular carcinoma (HCC). Hepatology (Baltimore, Md.).

Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.
Singal, A. G., Rich, N. E., Mehta, N., Branch, A., Pillai, A., Hoteit, M., … Parikh, N. D. (2019). Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. Gastroenterology, 156(6), 1683–92.e1.

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Ricketts, C. J., De Cubas, A. A., Fan, H., Smith, C. C., Lang, M., Reznik, E., … Linehan, W. M. (2018). The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Reports, 23(1), 313–26.e5.

Hepatocellular Carcinoma Surveillance: An Effective But Complex Process
Singal, A. G., & Murphy, C. C. (2019). Hepatocellular Carcinoma Surveillance: An Effective But Complex Process. GASTROENTEROLOGY, 156(4), 1215.

Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy
Dhanasekaran, R., Nault, J.-C., Roberts, L. R., & Zucman-Rossi, J. (2019). Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy. GASTROENTEROLOGY, 156(2), 492–509.

Prospective Multi-Regional Study of Down-Staging of Hepatocellular Carcinoma to within Milan Criteria before Liver Transplantation.
Mehta, N., Guy, J., Frenette, C., Tabrizian, P., Hoteit, M., Dhanasekaran, R., … Yao, F. (2019). Prospective Multi-Regional Study of Down-Staging of Hepatocellular Carcinoma to within Milan Criteria before Liver Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 19, 378–79.

Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients with Hepatocellular Carcinoma.
Rich, N. E., Yang, J. D., Perumalswami, P. V., Alkhouri, N., Jackson, W., Parikh, N. D., … Singal, A. G. (2019). Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients with Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Direct-Acting Antiviral Therapy for HCV Infection is Associated with Increased Survival in Patients With a History of Hepatocellular Carcinoma.
Singal, A. G., Rich, N. E., Mehta, N., Branch, A., Pillai, A., Hoteit, M., … Murphy, C. C. (2019). Direct-Acting Antiviral Therapy for HCV Infection is Associated with Increased Survival in Patients With a History of Hepatocellular Carcinoma. Gastroenterology.

The Immune Landscape of Cancer.
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., … Shmulevich, I. (2019). The Immune Landscape of Cancer. Immunity, 51(2), 411–12.

A Tale of Two Complications of Obesity: NASH and Hepatocellular Carcinoma
Dhanasekaran, R., & Felsher, D. W. (2019). A Tale of Two Complications of Obesity: NASH and Hepatocellular Carcinoma. HEPATOLOGY, 70(3), 1056–58.

Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma
Lai, I., Swaminathan, S., Baylot, V., Mosley, A., Dhanasekaran, R., Gabay, M., & Felsher, D. W. (2018). Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 6.

CLINICOPATHOLOGICAL FEATURES OF NONALCOHOLIC STEATOHEPATITIS (NASH)-RELATED HEPATOCELLULAR CARCINOMA (HCC)
Arjunan, V., Prabhakar, V., Raghavan, S. S., Tulu, Z., Kambham, N., Ahmed, A., … Dhanasekaran, R. (2019). CLINICOPATHOLOGICAL FEATURES OF NONALCOHOLIC STEATOHEPATITIS (NASH)-RELATED HEPATOCELLULAR CARCINOMA (HCC). HEPATOLOGY, 70, 548A.

IS IT GOOD IDEA TO OFFER TRANSPLANT EXCEPTION POINTS FOR SEPTUAGENARIANS WITH HEPATOCELLULAR CARCINOMA (HCC)?
Arjunan, V., Prabhakar, V., Raghavan, S. S., Tulu, Z., Kambham, N., Ahmed, A., … Dhanasekaran, R. (2019). IS IT GOOD IDEA TO OFFER TRANSPLANT EXCEPTION POINTS FOR SEPTUAGENARIANS WITH HEPATOCELLULAR CARCINOMA (HCC)? HEPATOLOGY, 70, 557A–558A.

THE ROLE OF LOCOREGIONAL THERAPY (LRT), POST LRT IMAGING, AND EXPLANT PATHOLOGY AS PREDICTORS OF HEPATOCELLULAR CARCINOMA (HCC) RECURRENCE POST ORTHOTOPIC LIVER TRANSPLANT (OLT)
Prabhakar, V., Dhanasekaran, R., Arjunan, V., Tulu, Z., Ahmed, A., Daugherty, T., … Kwo, P. Y. (2019). THE ROLE OF LOCOREGIONAL THERAPY (LRT), POST LRT IMAGING, AND EXPLANT PATHOLOGY AS PREDICTORS OF HEPATOCELLULAR CARCINOMA (HCC) RECURRENCE POST ORTHOTOPIC LIVER TRANSPLANT (OLT). HEPATOLOGY. WILEY.

CROSS-SPECIES COMPREHENSIVE PROTEOMIC ANALYSIS OF HEPATOCELLULAR CARCINOMA (HCC) TO IDENTIFY PLASMA BIOMARKERS OF VASCULAR INVASION
Krishnan, M., Arjunan, V., Kothary, N., Felsher, D., & Dhanasekaran, R. (2019). CROSS-SPECIES COMPREHENSIVE PROTEOMIC ANALYSIS OF HEPATOCELLULAR CARCINOMA (HCC) TO IDENTIFY PLASMA BIOMARKERS OF VASCULAR INVASION. HEPATOLOGY, 70, 74A.

DIRECT-ACTING ANTIVIRAL THERAPY IS ASSOCIATED WITH IMPROVED SURVIVAL IN PATIENTS WITH A HISTORY OF HEPATOCELLULAR CARCINOMA: A MULTICENTER NORTH AMERICAN COHORT STUDY
Singal, A. G., Rich, N. E., Mehta, N., Branch, A. D., Pillai, A. A., Hoteit, M. A., … Murphy, C. (2019). DIRECT-ACTING ANTIVIRAL THERAPY IS ASSOCIATED WITH IMPROVED SURVIVAL IN PATIENTS WITH A HISTORY OF HEPATOCELLULAR CARCINOMA: A MULTICENTER NORTH AMERICAN COHORT STUDY. HEPATOLOGY, 70, 130A–131A.

Oncogenic Signaling Pathways in The Cancer Genome Atlas
Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W. K., Luna, A., La, K. C., … Schultz, N. (2018). Oncogenic Signaling Pathways in The Cancer Genome Atlas. CELL, 173(2), 321-+.

Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas
Schaub, F. X., Dhankani, V., Berger, A. C., Trivedi, M., Richardson, A. B., Shaw, R., … Grandori, C. (2018). Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas. CELL SYSTEMS, 6(3), 282-+.

MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity.
Dhanasekaran, R., Baylot, V., Kim, M., Kuruvilla, S., Bellovin, D. I., Adeniji, N., … Felsher, D. W. (2020). MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity. ELife, 9.

Decline in Annual Mortality of Hepatitis C Virus-related Hepatocellular Carcinoma in the United States, From 2009 to 2018.
Kim, D., Konyn, P., Cholankeril, G., Wong, R. J., Younossi, Z. M., & Ahmed, A. (2020). Decline in Annual Mortality of Hepatitis C Virus-related Hepatocellular Carcinoma in the United States, From 2009 to 2018. Gastroenterology.

High Mortality Rates for SARS-CoV-2 Infection in Patients with Pre-existing Chronic Liver Disease and Cirrhosis: Preliminary Results from an International Registry.
Moon, A. M., Webb, G. J., Aloman, C., Armstrong, M. J., Cargill, T., Dhanasekaran, R., … Marjot, T. (2020). High Mortality Rates for SARS-CoV-2 Infection in Patients with Pre-existing Chronic Liver Disease and Cirrhosis: Preliminary Results from an International Registry. Journal of Hepatology.

MYC functions as a switch for natural killer cell-mediated immune surveillance of lymphoid malignancies.
Swaminathan, S., Hansen, A. S., Heftdal, L. D., Dhanasekaran, R., Deutzmann, A., Fernandez, W. D., … Felsher, D. W. (2020). MYC functions as a switch for natural killer cell-mediated immune surveillance of lymphoid malignancies. Nature Communications, 11(1), 2860.

One world, one pandemic, many guidelines: management of liver diseases during COVID-19.
Bollipo, S., Kapuria, D., Rabiee, A., Ben-Yakov, G., Lui, R. N., Lee, H. W., … Dhanasekaran, R. (2020). One world, one pandemic, many guidelines: management of liver diseases during COVID-19. Gut.

Roadmap to Resuming Care for Liver Diseases after COVID-19.
Kapuria, D., Bollipo, S., Rabiee, A., Ben Yakov, G., Kumar, G., Siau, K., … Lui, R. N. (2020). Roadmap to Resuming Care for Liver Diseases after COVID-19. Journal of Gastroenterology and Hepatology.

Spontaneous Regression of HCC- When the Immune System Stands Up to Cancer.
Arjunan, V., Hansen, A., Deutzmann, A., Sze, D. Y., & Dhanasekaran, R. (2020). Spontaneous Regression of HCC- When the Immune System Stands Up to Cancer. Hepatology (Baltimore, Md.).

A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-ß Superfamily.
Korkut, A., Zaidi, S., Kanchi, R. S., Rao, S., Gough, N. R., Schultz, A., … Akbani, R. (2018). A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-ß Superfamily. Cell Systems, 7(4), 422–37.e7.

A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
Berger, A. C., Korkut, A., Kanchi, R. S., Hegde, A. M., Lenoir, W., Liu, W., … Akbani, R. (2018). A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. Cancer Cell, 33(4), 690–705.e9.

MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCC.
Dhanasekaran, R., Park, J., Yevtodiyenko, A., Bellovin, D. I., Adam, S. J., Kd, A. R., … Felsher, D. W. (2020). MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCC. Molecular Therapy. Nucleic Acids, 21, 850–59.

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb, G. J., Marjot, T., Cook, J. A., Aloman, C., Armstrong, M. J., Brenner, E. J., … Moon, A. M. (2020). Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study. The Lancet. Gastroenterology & Hepatology.

MYC Oncogene Abrogates Natural Killer (NK) Cell-Mediated Immune Surveillance of B- and T-Lymphoid Malignancies By Suppressing STAT1/2-Type I IFN Signaling
Swaminathan, S., Heftdal, L. D., Liefwalker, D., Dhanasekaran, R., Deutzmann, A., Horton, C., … Felsher, D. (2019). MYC Oncogene Abrogates Natural Killer (NK) Cell-Mediated Immune Surveillance of B- and T-Lymphoid Malignancies By Suppressing STAT1/2-Type I IFN Signaling. BLOOD, 134.

Predictors of Outcomes of COVID-19 in Patients with Chronic Liver Disease: US Multi-center Study.
Kim, D., Adeniji, N., Latt, N., Kumar, S., Bloom, P. P., Aby, E. S., … Dhanasekaran, R. (2020). Predictors of Outcomes of COVID-19 in Patients with Chronic Liver Disease: US Multi-center Study. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Liver Injury in Liver Transplant Recipients with Coronavirus Disease 2019 (COVID-19): US Multicenter Experience.
Rabiee, A., Sadowski, B., Adeniji, N., Perumalswami, P., Nguyen, V., Moghe, A., … Dhanasekaran, R. (2020). Liver Injury in Liver Transplant Recipients with Coronavirus Disease 2019 (COVID-19): US Multicenter Experience. Hepatology (Baltimore, Md.).

MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCC
Dhanasekaran, R., Park, J., Yevtodiyenko, A., Bellovin, D. I., Adam, S. J., Rajan, A., … Felsher, D. W. (2020). MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCC. MOLECULAR THERAPY-NUCLEIC ACIDS, 21, 850–59.

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study.
Marjot, T., Moon, A. M., Cook, J. A., Abd-Elsalam, S., Aloman, C., Armstrong, M. J., … Webb, G. J. (2020). Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study. Journal of Hepatology.

Transarterial Chemoembolization and Radio-Embolization are Similarly Efficacious in Achieving Successful Hepatocellular Carcinoma (HCC) Down-Staging: Results from the Multicenter Evaluation of Reduction in Tumor Size Before Liver Transplantation (MERITS-LT) Consortium
Mehta, N., Guy, J., Frenette, C., Tabrizian, P., Hoteit, M., Parikh, N., … Yao, F. (2020). Transarterial Chemoembolization and Radio-Embolization are Similarly Efficacious in Achieving Successful Hepatocellular Carcinoma (HCC) Down-Staging: Results from the Multicenter Evaluation of Reduction in Tumor Size Before Liver Transplantation (MERITS-LT) Consortium. AMERICAN JOURNAL OF TRANSPLANTATION, 20, 489.

Impact of Bridging Locoregional Therapies for Hepatocellular Carcinoma on Post-Transplant Clinical Outcome.
Adeniji, N., Arjunan, V., Prabhakar, V., Tulu, Z., Kambham, N., Ahmed, A., … Dhanasekaran, R. (2020). Impact of Bridging Locoregional Therapies for Hepatocellular Carcinoma on Post-Transplant Clinical Outcome. Clinical Transplantation, e14128.

Genomic analysis of Vascular Invasion in Hepatocellular Carcinoma (HCC) Reveals Molecular Drivers and Predictive Biomarkers.
Krishnan, M. S., Rajan Kd, A., Park, J., Arjunan, V., Garcia Marques, F. J., Bermudez, A., … Dhanasekaran, R. (2020). Genomic analysis of Vascular Invasion in Hepatocellular Carcinoma (HCC) Reveals Molecular Drivers and Predictive Biomarkers. Hepatology (Baltimore, Md.).

THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B VIRUS INFECTION SUBJECTS NOT MEETING CRITERIA FOR ANTIVIRAL THERAPY
Alshuwaykh, O., Goel, A., Daugherty, T., Cheung, A., Kim, W. R., Kwong, A. J., … Kwo, P. Y. (2020). THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B VIRUS INFECTION SUBJECTS NOT MEETING CRITERIA FOR ANTIVIRAL THERAPY. HEPATOLOGY. WILEY.

PREDICTORS OF OUTCOMES OF COVID-19 IN PATIENTS WITH CHRONIC LIVER DISEASE: US MULTI-CENTER STUDY
Adeniji, N., Kim, D., Latt, N. L., Kumar, S., Bloom, P. P., Aby, E. S., … Dhanasekaran, R. (2020). PREDICTORS OF OUTCOMES OF COVID-19 IN PATIENTS WITH CHRONIC LIVER DISEASE: US MULTI-CENTER STUDY. HEPATOLOGY. WILEY.

PATTERNS AND PREDICTORS OF LIVER INJURY IN LIVER TRANSPLANT RECIPIENTS WITH CORONAVIRUS DISEASE 2019 (COVID-19)
Rabiee, A., Sadowski, B., Adeniji, N., Nguyen, V., Moghe, A., Perumalswami, P. V., … Dhanasekaran, R. (2020). PATTERNS AND PREDICTORS OF LIVER INJURY IN LIVER TRANSPLANT RECIPIENTS WITH CORONAVIRUS DISEASE 2019 (COVID-19). HEPATOLOGY, 72, 295A.

Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities with Chronic Liver Diseases (CLD).
Adeniji, N., Carr, R. M., Aby, E. S., Catana, A. M., Wegermann, K., & Dhanasekaran, R. (2020). Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities with Chronic Liver Diseases (CLD). Gastroenterology.

Pathogenic Germline Variants in 10,389 Adult Cancers.
Huang, K.-L. L., Mashl, R. J., Wu, Y., Ritter, D. I., Wang, J., Oh, C., … Ding, L. (2018). Pathogenic Germline Variants in 10,389 Adult Cancers. Cell, 173(2), 355–70.e14.

Post-Transplant Outcomes in Older Patients with Hepatocellular Carcinoma (HCC) are Driven by non-HCC Factors.
Adeniji, N., Arjunan, V., Prabhakar, V., Mannalithara, A., Ghaziani, T., Ahmed, A., … Dhanasekaran, R. (2020). Post-Transplant Outcomes in Older Patients with Hepatocellular Carcinoma (HCC) are Driven by non-HCC Factors. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation
Alshuwaykh, O., Kwong, A., Goel, A., Cheung, A., Dhanasekaran, R., Ahmed, A., … Kwo, P. Y. (2020). Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation. HEPATOLOGY COMMUNICATIONS.

Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches
Dhanasekaran, R. (2021). Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches. SEMINARS IN LIVER DISEASE.

Clinical Response to Treatment for Acute Kidney Injury (AKI) in Patients With Cirrhosis
John, N., Alshuwaykh, O., Goel, A., Ahmed, A., Cheung, A., Dronamraju, D., … Kwo, P. Y. (2020). Clinical Response to Treatment for Acute Kidney Injury (AKI) in Patients With Cirrhosis. AMERICAN JOURNAL OF GASTROENTEROLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Characterizing Ascites in Subjects With Nonhepatic Solid Tumors
Alshuwaykh, O., Cheung, A., Goel, A., Dhanasekaran, R., Ahmed, A., Dronamraju, D., … Kwo, P. Y. (2020). Characterizing Ascites in Subjects With Nonhepatic Solid Tumors. AMERICAN JOURNAL OF GASTROENTEROLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation.
Alshuwaykh, O., Kwong, A., Goel, A., Cheung, A., Dhanasekaran, R., Ahmed, A., … Kwo, P. Y. (2021). Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation. Hepatology Communications, 5(3), 516–525.

Outcome of COVID-19 in Patients with Autoimmune Hepatitis: an International Multi-Centre Study.
Efe, C., Dhanasekaran, R., Lammert, C., Ebi, B., Higuera-de la Tijera, F., Aloman, C., … Wahlin, S. (2021). Outcome of COVID-19 in Patients with Autoimmune Hepatitis: an International Multi-Centre Study. Hepatology (Baltimore, Md.).

Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches.
Dhanasekaran, R. (2021). Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches. Seminars in Liver Disease, 41(1), 9–18.

Genomic Landscape of HCC.
Nia, A., & Dhanasekaran, R. (2020). Genomic Landscape of HCC. Current Hepatology Reports, 19(4), 448–61.

Hepatitis C and Hepatocellular Cancer: To Treat or Not to Treat.
Dhanasekaran, R., & Kwo, P. Y. (2021). Hepatitis C and Hepatocellular Cancer: To Treat or Not to Treat. Clinical Liver Disease, 17(3), 169–73.

Influence of Patient Age on Short Term and Long Term Survival After Tips
Dhanasekaran, R., Parekh, S., & Kim, H. S. (2010). Influence of Patient Age on Short Term and Long Term Survival After Tips. GASTROENTEROLOGY. W B SAUNDERS CO-ELSEVIER INC.

Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Wang, Y., Xu, X., Maglic, D., Dill, M. T., Mojumdar, K., Ng, P. K.-S., … Liang, H. (2018). Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer. CELL REPORTS, 25(5), 1304-+.

Radioembolization for unresectable chemorefractory hepatic metastases - Safety and efficacy
Dhanasekaran, R., Kooby, D., Staley, C., Kauh, J., Montilla-Soler, J., Barron, B., & Kim, H. (2009). Radioembolization for unresectable chemorefractory hepatic metastases - Safety and efficacy. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC.

MYC functions as a master switch for natural killer cell-mediated immune surveillance of lymphoid malignancies
Swaminathan, S., Mosley, A., Horton, C., Liefwalker, D. F., Deutzmann, A., Dhanasekaran, R., … Felsher, D. W. (2017). MYC functions as a master switch for natural killer cell-mediated immune surveillance of lymphoid malignancies. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.

Comprehensive Characterization of Cancer Driver Genes and Mutations (vol 173, 371.e1, 2018)
Bailey, M. H., Tokheim, C., Porta-Pardo, E., Sengupta, S., Bertrand, D., Weerasinghe, A., … Ding, L. (2018). Comprehensive Characterization of Cancer Driver Genes and Mutations (vol 173, 371.e1, 2018). CELL, 174(4), 1034–1035.

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
Kahles, A., Lehmann, K.-V., Toussaint, N. C., Huser, M., Stark, S. G., Sachsenberg, T., … Ratsch, G. (2018). Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients. CANCER CELL, 34(2), 211-+.

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (vol 23, pg 313, 2018)
Ricketts, C. J., De Cubas, A. A., Fan, H., Smith, C. C., Lang, M., Reznik, E., … Linehan, W. M. (2018). The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (vol 23, pg 313, 2018). CELL REPORTS, 23(12), 3698.

lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer
Wang, Z., Yang, B., Zhang, M., Guo, W., Wu, Z., Wang, Y., … Yang, D. (2018). lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer. CANCER CELL, 33(4), 706-+.

Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
Knijnenburg, T. A., Wang, L., Zimmermann, M. T., Chambwe, N., Gao, G. F., Cherniack, A. D., … Wang, C. (2018). Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. CELL REPORTS, 23(1), 239-+.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Liu, J., Lichtenberg, T., Hoadley, K. A., Poisson, L. M., Lazar, A. J., Cherniack, A. D., … Hu, H. (2018). An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. CELL, 173(2), 400-+.

Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
Saltz, J., Gupta, R., Hou, L., Kurc, T., Singh, P., Vu Nguyen, … Thorsson, V. (2018). Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images. CELL REPORTS, 23(1), 181-+.

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
Hoadley, K. A., Yau, C., Hinoue, T., Wolf, D. M., Lazar, A. J., Drill, E., … Laird, P. W. (2018). Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. CELL, 173(2), 291-+.

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas
Way, G. P., Sanchez-Vega, F., La, K., Armenia, J., Chatila, W. K., Luna, A., … Greene, C. S. (2018). Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas. CELL REPORTS, 23(1), 172-+.

Systematic Analysis of Splice-Site-Creating Mutations in Cancer
Jayasinghe, R. G., Cao, S., Gao, Q., Wendl, M. C., Vo, N. S., Reynolds, S. M., … Ding, L. (2018). Systematic Analysis of Splice-Site-Creating Mutations in Cancer. CELL REPORTS, 23(1), 270-+.

Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types
Seiler, M., Peng, S., Agrawal, A. A., Palacino, J., Teng, T., Zhu, P., … Yu, L. (2018). Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types. CELL REPORTS, 23(1), 282-+.

A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples
Chen, H., Li, C., Peng, X., Zhou, Z., Weinstein, J. N., & Liang, H. (2018). A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples. CELL, 173(2), 386-+.

Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context
Chiu, H.-S., Somvanshi, S., Patel, E., Chen, T.-W., Singh, V. P., Zorman, B., … Sumazin, P. (2018). Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context. CELL REPORTS, 23(1), 297-+.

Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types
Ge, Z., Leighton, J. S., Wang, Y., Peng, X., Chen, Z., Chen, H., … Liang, H. (2018). Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types. CELL REPORTS, 23(1), 213-+.

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
Ding, L., Bailey, M. H., Porta-Pardo, E., Thorsson, V., Colaprico, A., Bertrand, D., … Getz, G. (2018). Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics. CELL, 173(2), 305-+.

Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Taylor, A. M., Shih, J., Ha, G., Gao, G. F., Zhang, X., Berger, A. C., … Meyerson, M. (2018). Genomic and Functional Approaches to Understanding Cancer Aneuploidy. CANCER CELL, 33(4), 676-+.

Comprehensive Characterization of Cancer Driver Genes and Mutations
Bailey, M. H., Tokheim, C., Porta-Pardo, E., Sengupta, S., Bertrand, D., Weerasinghe, A., … Ding, L. (2018). Comprehensive Characterization of Cancer Driver Genes and Mutations. CELL, 173(2), 371-+.

Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
Gao, Q., Liang, W.-W., Foltz, S. M., Mutharasu, G., Jayasinghe, R. G., Cao, S., … Ding, L. (2018). Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. CELL REPORTS, 23(1), 227-+.

Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
Ellrott, K., Bailey, M. H., Saksena, G., Covington, K. R., Kandoth, C., Stewart, C., … Ding, L. (2018). Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines. CELL SYSTEMS, 6(3), 271-+.

Identification of Novel Fusions in Gallbladder Cancer by Next Generation Sequencing RNA Analysis - Potential for Targeted Therapy
Allotey, L. K., Nair, A., Chaiteerakij, R., Oliver, G., O'Brien, D., Sarangi, V., … Roberts, L. (2016). Identification of Novel Fusions in Gallbladder Cancer by Next Generation Sequencing RNA Analysis - Potential for Targeted Therapy. GASTROENTEROLOGY. W B SAUNDERS CO-ELSEVIER INC.

Sulfatase2 (SULF2) Promotes Angiogenesis in Hepatocellular Carcinoma Partly Through the TGF beta 1/Periostin Signaling Pathway
Chen, G., Miamen, A., Dhanasekaran, R., Moser, C. D., Han, S., Chen, Y., … Roberts, L. R. (2014). Sulfatase2 (SULF2) Promotes Angiogenesis in Hepatocellular Carcinoma Partly Through the TGF beta 1/Periostin Signaling Pathway. GASTROENTEROLOGY. W B SAUNDERS CO-ELSEVIER INC.

Comparing Internet Search Patterns for Gastroenterological Diagnoses to Physician Visit Data
Dhanasekaran, R., & Oxentenko, A. (2013). Comparing Internet Search Patterns for Gastroenterological Diagnoses to Physician Visit Data. AMERICAN JOURNAL OF GASTROENTEROLOGY. NATURE PUBLISHING GROUP.

KLATSKIN TUMOR- CLINICAL OUTCOME AND PROGNOSTIC FACTORS
Dhanasekaran, R., Hemming, A. W., Nelson, D. R., Soldevila-Pico, C., Firpi, R. J., Morelli, G., … Cabrera, R. (2011). KLATSKIN TUMOR- CLINICAL OUTCOME AND PROGNOSTIC FACTORS. HEPATOLOGY. WILEY-BLACKWELL.

PANCRELIPASE FOR PANCREATIC DISORDERS: AN UPDATE
Dhanasekaran, R., & Toskes, P. P. (2010). PANCRELIPASE FOR PANCREATIC DISORDERS: AN UPDATE. DRUGS OF TODAY, 46(11), 855–866.

Chemoembolization Combined with Radiofrequency Ablation for Hepato cellular Carcinoma; Survival Benefits and Tumor Treatment Response
Dhanasekaran, R., Khanna, Kooby, D., Delman, K., Staley, C., Kauh, J., … Kim, H. (2009). Chemoembolization Combined with Radiofrequency Ablation for Hepato cellular Carcinoma; Survival Benefits and Tumor Treatment Response. AMERICAN JOURNAL OF ROENTGENOLOGY. AMER ROENTGEN RAY SOC.

Down-staging Outcomes for Hepatocellular Carcinoma: Results from the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.
Mehta, N., Frenette, C., Tabrizian, P., Hoteit, M., Guy, J., Parikh, N., … Yao, F. Y. (2021). Down-staging Outcomes for Hepatocellular Carcinoma: Results from the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium. Gastroenterology.

Screening for Hepatocellular Carcinoma in Patients with Hepatitis B
Sachar, Y., Brahmania, M., Dhanasekaran, R., & Congly, S. E. (2021). Screening for Hepatocellular Carcinoma in Patients with Hepatitis B. VIRUSES-BASEL, 13(7).

Screening for Hepatocellular Carcinoma in Patients with Hepatitis B.
Sachar, Y., Brahmania, M., Dhanasekaran, R., & Congly, S. E. (2021). Screening for Hepatocellular Carcinoma in Patients with Hepatitis B. Viruses, 13(7).

The MYC oncogene - the grand orchestrator of cancer growth and immune evasion.
Dhanasekaran, R., Deutzmann, A., Mahauad-Fernandez, W. D., Hansen, A. S., Gouw, A. M., & Felsher, D. W. (2021). The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nature Reviews. Clinical Oncology.

Current and Emerging Tools for Hepatocellular Carcinoma Surveillance.
Adeniji, N., & Dhanasekaran, R. (2021). Current and Emerging Tools for Hepatocellular Carcinoma Surveillance. Hepatology Communications.

Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
Mattos, A. Z., Debes, J. D., Dhanasekaran, R., Benhammou, J. N., Arrese, M., Patricio, A. L., … Mattos, A. A. (2021). Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge. WORLD JOURNAL OF HEPATOLOGY, 13(9), 1107–1121.

Liver transplantation for hepatocellular carcinoma
Lo, C. M., & Fan, S. T. (2004). Liver transplantation for hepatocellular carcinoma. BRITISH JOURNAL OF SURGERY, 91(2), 131–133.

Morphological heterogeneity in beta-catenin-mutated hepatocellular carcinomas: implications for tumor molecular classification.
Torbenson, M., McCabe, C. E., O'Brien, D. R., Yin, J., Bainter, T., Tran, N. H., … Wang, C. (2021). Morphological heterogeneity in beta-catenin-mutated hepatocellular carcinomas: implications for tumor molecular classification. Human Pathology, 119, 15–27.

Outcomes of Downstaging Hepatocellular Carcinoma (HCC) to within Milan Criteria Before Liver Transplantation (LT): A Multicenter Analysis of the "All-comers" Protocol
Natarajan, B., Tabrizian, P., Hoteit, M., Frenette, C., Ghaziani, T., Dhanasekaran, R., … Mehta, N. (2021). Outcomes of Downstaging Hepatocellular Carcinoma (HCC) to within Milan Criteria Before Liver Transplantation (LT): A Multicenter Analysis of the "All-comers" Protocol. AMERICAN JOURNAL OF TRANSPLANTATION. WILEY.

Recent Progress in Systemic Therapy for Hepatocellular Cancer (HCC).
Ghaziani, T. T., & Dhanasekaran, R. (2021). Recent Progress in Systemic Therapy for Hepatocellular Cancer (HCC). . Current Treatment Options in Gastroenterology , 19(1).

THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B VIRUS INFECTION SUBJECTS WITH CIRRHOSIS NOT MEETING CURRENT TREATMENT GUIDANCE
Alshuwaykh, O., Goel, A., Ghaziani, T. T., Daugherty, T., Dhanasekaran, R., Ahmed, A., … Kwo, P. Y. (2021). THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B VIRUS INFECTION SUBJECTS WITH CIRRHOSIS NOT MEETING CURRENT TREATMENT GUIDANCE. HEPATOLOGY. WILEY.

DISTINCT IMMUNE MECHANISMS OF COMBINED PD-L1 AND CTLA-4 BLOCKADE IN HEPATOCELLULAR CARCINOMA (HCC)
Dhanasekaran, R., Hansen, A. S., Park, J., Lai, I., Adeniji, N., Kuruvilla, S., & Felsher, D. (2021). DISTINCT IMMUNE MECHANISMS OF COMBINED PD-L1 AND CTLA-4 BLOCKADE IN HEPATOCELLULAR CARCINOMA (HCC). HEPATOLOGY. WILEY.

LONG-TERM CLINICAL OUTCOMES OF PATIENTS WITH COVID-19 AND CHRONIC LIVER DISEASE: US MULTICENTER STUDY COLD STUDY
Aby, E., Gustafson, J. L., Daidone, M., Chung, R. T., Sandhu, S., Sohal, A., … Dhanasekaran, R. (2021). LONG-TERM CLINICAL OUTCOMES OF PATIENTS WITH COVID-19 AND CHRONIC LIVER DISEASE: US MULTICENTER STUDY COLD STUDY. HEPATOLOGY. WILEY.

Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis.
Efe, C., Lammert, C., Tascilar, K., Dhanasekaran, R., Ebik, B., Higuera-de la Tijera, F., … Wahlin, S. (2021). Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis. Liver International : Official Journal of the International Association for the Study of the Liver.

Treacherous apoptosis- cancer cells sacrifice themselves at the altar of heterogeneity.
Dhanasekaran, R. (2022). Treacherous apoptosis- cancer cells sacrifice themselves at the altar of heterogeneity. Hepatology (Baltimore, Md.).

Implications of genetic heterogeneity in hepatocellular cancer.
Suresh, A., & Dhanasekaran, R. (2022). Implications of genetic heterogeneity in hepatocellular cancer. Advances in Cancer Research, 156, 103–135.

Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy.
Alshuwaykh, O., Daugherty, T., Cheung, A., Goel, A., Dhanasekaran, R., Ghaziani, T. T., … Kwo, P. Y. (2022). Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy. Hepatology Communications.

Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites.
Alshuwaykh, O., Cheung, A., Goel, A., Kwong, A., Dhanasekaran, R., Ghaziani, T. T., … Kwo, P. Y. (2022). Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites. BMC Gastroenterology, 22(1), 410.

SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis.
Efe, C., Tascilar, K., Gerussi, A., Bolis, F., Lammert, C., Ebik, B., … Wahlin, S. (2022). SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis. Journal of Autoimmunity, 132, 102906.

MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changes.
Sullivan, D. K., Deutzmann, A., Yarbrough, J., Krishnan, M. S., Gouw, A. M., Bellovin, D. I., … Felsher, D. W. (2022). MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changes. Oncogene.

MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma that is Reversible Through Restoration of Pro-Inflammatory Macrophages.
Dhanasekaran, R., Hansen, A. S., Park, J., Lemaitre, L., Lai, I., Adeniji, N., … Felsher, D. W. (2022). MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma that is Reversible Through Restoration of Pro-Inflammatory Macrophages. Cancer Research.

SPATIAL MULTI-OMIC IMMUNE PROFILING AND FUNCTIONAL CHARACTERIZATION OF HEPATOCELLULAR CARCINOMA (HCC) REVEAL MECHANISMS OF MINIMAL RESIDUAL DISEASE (MRD)
Suresh, A., Adeniji, N., Lemaitre, L., Charu, V., & Dhanasekaran, R. (2022). SPATIAL MULTI-OMIC IMMUNE PROFILING AND FUNCTIONAL CHARACTERIZATION OF HEPATOCELLULAR CARCINOMA (HCC) REVEAL MECHANISMS OF MINIMAL RESIDUAL DISEASE (MRD). HEPATOLOGY. WILEY.

Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.
Aby, E. S., Moafa, G., Latt, N., Sultan, M. T., Cacioppo, P. A., Kumar, S., … Dhanasekaran, R. (2023). Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study. Hepatology Communications, 7(1), e8874.